 | | PRD_000855 | | Name: | DB5 peptide | | Formula: | C49 H74 N15 O10 S | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000892 | | Name: | METHYL (2R)-1-[(6S,9S,12S,13S,17S,20S,23R)-9-(3-AMINO-3-OXOPROPYL)-12,23-DIBENZYL-13-HYDROXY-2,2,8,20,22-PENTAMETHYL-17-(2-METHYLPROPYL)-4,7,10,15,18,21,24-HEPTAOXO-6-(PROPAN-2-YL)-3-OXA-5,8,11,16,19,22-HEXAAZATETRACOSAN-24-YL]PYRROLIDINE-2-CARBOXYLATE | | Formula: | C52 H78 N8 O12 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000893 | | Name: | METHYL (2S)-1-[(2R,5S,8S,12S,13S)-2,13-DIBENZYL-12-HYDROXY-3,5-DIMETHYL-15-(3-[METHYL(METHYLSULFONYL)AMINO]-5-{[(1R)-1-PHENYLETHYL]CARBAMOYL}PHENYL)-8-(2-METHYLPROPYL)-4,7,10,15-TETRAOXO-3,6,9,14-TETRAAZAPENTADECAN-1-OYL]PYRROLIDINE-2-CARBOXYLATE | | Formula: | C54 H69 N7 O11 S | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000915 | | Name: | benzyl [(2S)-1-({(2R)-1-[(1S,2S)-2-{[(2R,3S,4S)-3-formyl-2-hydroxy-4-methylhexanoyl]amino}cyclopropyl]-4-phenylbutan-2-yl}amino)-1-oxopropan-2-yl]carbamate | | Formula: | C32 H43 N3 O6 | | Definition date: | 2013-04-17 | | Last modified: | 2013-04-17 |
|
 | | PRD_001012 | | Name: | Pyrrhocoricin | | Formula: | C72 H120 N16 O18 | | Definition date: | 2013-04-17 | | Last modified: | 2013-04-17 |
|
 | | PRD_001043 | | Name: | (2R)-2,4-dihydroxy-3,3-dimethyl-N-[3-oxo-3-(pentylamino)propyl]butanamide | | Formula: | C14 H28 N2 O4 | | Definition date: | 2013-04-10 | | Last modified: | 2013-04-10 |
|
 | | PRD_000830 | | Name: | N-[(2S)-3-[(S)-(4-bromophenyl)(hydroxy)phosphoryl]-2-{[3-(3'-chlorobiphenyl-4-yl)-1,2-oxazol-5-yl]methyl}propanoyl]-L-alpha-glutamyl-L-alpha-glutamine | | Formula: | C35 H35 Br Cl N4 O10 P | | Definition date: | 2013-02-06 | | Last modified: | 2013-02-06 |
|
 | | PRD_000865 | | Name: | N-[(2S)-3-[(R)-(4-bromophenyl)(hydroxy)phosphoryl]-2-{[3-(3'-chlorobiphenyl-4-yl)-1,2-oxazol-5-yl]methyl}propanoyl]-L-a
lanyl-L-alaninamide | | Formula: | C31 H31 Br Cl N4 O6 P | | Definition date: | 2013-02-06 | | Last modified: | 2013-02-06 |
|
 | | PRD_000866 | | Name: | N-{(2S)-3-[(S)-(4-bromophenyl)(hydroxy)phosphoryl]-2-[(3-phenyl-1,2-oxazol-5-yl)methyl]propanoyl}-L-alpha-glutamyl-L-al
pha-glutamine | | Formula: | C29 H32 Br N4 O10 P | | Definition date: | 2013-02-06 | | Last modified: | 2013-02-06 |
|
 | | PRD_000868 | | Name: | N-{(2S)-3-[(R)-(4-bromophenyl)(hydroxy)phosphoryl]-2-[(3-phenyl-1,2-oxazol-5-yl)methyl]propanoyl}-L-alanyl-L-alaninamid
e | | Formula: | C25 H28 Br N4 O6 P | | Definition date: | 2013-02-06 | | Last modified: | 2013-02-06 |
|
 | | PRD_000908 | | Name: | N-(3-carboxypropanoyl)-L-valyl-N-[(1S)-2-phenyl-1-phosphonoethyl]-L-prolinamide | | Formula: | C22 H32 N3 O8 P | | Definition date: | 2013-01-23 | | Last modified: | 2013-01-23 |
|
 | | PRD_000920 | | Name: | SAMAROSPORIN I | | Formula: | C77 H120 N16 O19 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000944 | | Name: | N-{(2S)-1-[(2-chlorobenzyl)amino]-1-oxo-4-phenylbutan-2-yl}-N~2~-[3-(2-methylphenyl)propanoyl]-L-threoninamide | | Formula: | C31 H36 Cl N3 O4 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_001003 | | Name: | N-[(2S,4S,5S)-5-amino-4-hydroxy-1,6-diphenylhexan-2-yl]-N~2~-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-L-valinamide | | Formula: | C32 H45 N5 O3 S | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_001017 | | Name: | (S)-N-((1R,2S)-1-((2R,3R)-3-benzyloxiran-2-yl)-1-hydroxy-3-phenylpropan-2-yl)-3-methyl-2-(2-phenoxyacetamido)butanamide | | Formula: | C31 H36 N2 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_001038 | | Name: | 3-[[(2S)-2-[[[(2S)-2-[[(2S)-2-[[(2S)-2-azanyl-3-(1H-1,2,3,4-tetrazol-5-ylcarbonylamino)propanoyl]amino]-3-methyl-butanoyl]amino]-4-methyl-pentanoyl]amino]methyl]-2-hydroxy-4-phenyl-butanoyl]amino]benzoic acid | | Formula: | C34 H46 N10 O8 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_001050 | | Name: | N~2~-acetyl-N-{(1R)-1-[(S)-[(2S)-3-{[(2S)-1-amino-1-oxopropan-2-yl]amino}-2-methyl-3-oxopropyl](hydroxy)phosphoryl]-2-phenylethyl}-L-alpha-asparagine | | Formula: | C21 H31 N4 O8 P | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_001058 | | Name: | N-{3-[4-(4-phenylthiophen-2-yl)phenyl]propanoyl}-L-alpha-glutamyl-L-alpha-glutamyl-amide | | Formula: | C29 H31 N3 O7 S | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_001060 | | Name: | N~2~-{3-[4-(4-phenylthiophen-2-yl)phenyl]propanoyl}-L-glutaminyl-L-alpha-glutamine | | Formula: | C29 H32 N4 O6 S | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_001072 | | Name: | Thiocillin GE2270 analogue NVP-LFF571 | | Formula: | C60 H72 N13 O13 S6 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_001073 | | Name: | Thiocillin GE2270 analogue NVP-LDK733 | | Formula: | C55 H64 N13 O11 S6 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_001074 | | Name: | Thiocillin GE2270 analogue NVP-LDI028 | | Formula: | C55 H64 N13 O10 S6 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_001110 | | Name: | N-[(2R)-1-{[(2S,3S)-5-{[(2R)-1-{[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino}-3-chloro-1-oxopropan-2-yl]amino}-3-hydroxy-5-oxo-1-phenylpentan-2-yl]amino}-3-methyl-1-oxobutan-2-yl]pyridine-2-carboxamide | | Formula: | C31 H43 Cl N6 O6 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_001113 | | Name: | N-[(2S)-1-{[(2S,3S)-3-hydroxy-5-oxo-5-{[(2R)-1-oxo-3-phenyl-1-(prop-2-yn-1-ylamino)propan-2-yl]amino}-1-phenylpentan-2-yl]amino}-3-methyl-1-oxobutan-2-yl]pyridine-2-carboxamide | | Formula: | C34 H39 N5 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_001114 | | Name: | N-[(2S)-1-hydroxy-3-phenylpropan-2-yl]-Nalpha-[(2E)-3-phenylprop-2-enoyl]-L-phenylalaninamide | | Formula: | C27 H28 N2 O3 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
